BBHC
Brown Brothers Harriman & Co Portfolio holdings
AUM
$15.6B
1-Year Return
17.71%
This Quarter Return
+12.61%
1 Year Return
+17.71%
3 Year Return
+77.24%
5 Year Return
+124.29%
10 Year Return
+261.89%
AUM
$15B
AUM Growth
+$1.06B
(+7.6%)
Cap. Flow
-$526M
Cap. Flow
% of AUM
-3.51%
Top 10 Holdings %
Top 10 Hldgs %
36.77%
Holding
1,186
New
162
Increased
449
Reduced
214
Closed
84
Top Buys
| 1 |
Starbucks
SBUX
|
+$238M |
| 2 |
Graco
GGG
|
+$101M |
| 3 |
Linde
LIN
|
+$72.8M |
| 4 |
Visa
V
|
+$55M |
| 5 |
Amazon
AMZN
|
+$45.4M |
Top Sells
| 1 |
Oracle
ORCL
|
+$140M |
| 2 |
Copart
CPRT
|
+$107M |
| 3 |
Diageo
DEO
|
+$91.6M |
| 4 |
Celanese
CE
|
+$82.9M |
| 5 |
Waste Management
WM
|
+$72.3M |
Sector Composition
| 1 | Financials | 17.66% |
| 2 | Healthcare | 16.44% |
| 3 | Industrials | 13.92% |
| 4 | Consumer Staples | 12.28% |
| 5 | Consumer Discretionary | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Onto Innovation
ONTO
$5.36B
| $337K | ﹤0.01% |
7,095
-315
| -4% | -$15K |
|
352
Genuine Parts
GPC
$19.6B
| $335K | ﹤0.01% |
3,335
| – | – |
|
353
Pathward Financial
CASH
$1.73B
| $332K | ﹤0.01% |
9,070
+2,652
| +41% | +$97.1K |
|
354
iShares Gold Trust
IAU
$53.6B
| $332K | ﹤0.01% |
9,143
+6,393
| +232% | +$232K |
|
355
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.14B
| $331K | ﹤0.01% |
+3,838
| New | +$331K |
|
356
Jazz Pharmaceuticals
JAZZ
$7.78B
| $327K | ﹤0.01% |
1,982
+176
| +10% | +$29K |
|
357
JPMorgan BetaBuilders Europe ETF
BBEU
$4.22B
| $326K | ﹤0.01% |
+6,247
| New | +$326K |
|
358
Healthpeak Properties
DOC
$12.6B
| $325K | ﹤0.01% |
10,736
+809
| +8% | +$24.5K |
|
359
Sony
SONY
$174B
| $324K | ﹤0.01% |
16,010
+1,290
| +9% | +$26.1K |
|
360
Vanguard Mid-Cap Value ETF
VOE
$19B
| $323K | ﹤0.01% |
+2,717
| New | +$323K |
|
361
Zimmer Biomet
ZBH
$20.5B
| $322K | ﹤0.01% |
2,151
+435
| +25% | +$65.1K |
|
362
SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.23B
| $318K | ﹤0.01% |
6,064
| – | – |
|
363
Lam Research
LRCX
$147B
| $315K | ﹤0.01% |
6,660
+2,640
| +66% | +$125K |
|
364
GSK
GSK
$83.2B
| $313K | ﹤0.01% |
6,814
+79
| +1% | +$3.63K |
|
365
Revvity
RVTY
$9.76B
| $313K | ﹤0.01% |
2,184
| – | – |
|
366
Vanguard FTSE Europe ETF
VGK
$27.1B
| $313K | ﹤0.01% |
5,200
| – | – |
|
367
Eaton
ETN
$140B
| $311K | ﹤0.01% |
2,591
+1,421
| +121% | +$171K |
|
368
Willis Towers Watson
WTW
$33.2B
| $306K | ﹤0.01% |
1,454
-337
| -19% | -$70.9K |
|
369
Agilent Technologies
A
$35.6B
| $299K | ﹤0.01% |
2,524
+46
| +2% | +$5.45K |
|
370
Enerpac Tool Group
EPAC
$2.31B
| $298K | ﹤0.01% |
13,164
| – | – |
|
371
Jack Henry & Associates
JKHY
$11.8B
| $292K | ﹤0.01% |
1,800
| – | – |
|
372
Vanguard Small-Cap Value ETF
VBR
$31.8B
| $292K | ﹤0.01% |
+2,055
| New | +$292K |
|
373
CF Industries
CF
$14B
| $291K | ﹤0.01% |
7,530
| – | – |
|
374
Boston Scientific
BSX
$153B
| $290K | ﹤0.01% |
8,067
-706
| -8% | -$25.4K |
|
375
Amplify Cybersecurity ETF
HACK
$2.32B
| $288K | ﹤0.01% |
+5,000
| New | +$288K |
|